Conference
Excess body weight does not adversely influence either bioavailability or anticoagulant activity of enoxaparin administered subcutaneously in acute coronary syndromes
Authors
Becker RC; Spencer FA; Bruno R; Sanderink GJ; Ball SP; Antman EM
Volume
102
Pagination
pp. 427-428
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
October 31, 2000
Conference proceedings
CIRCULATION
Issue
18
ISSN
0009-7322